SEC
MRNA icon

Seven Eight Capital’s Moderna MRNA Stock Holding History

Seven Eight Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,072
Closed -$487K – 671
2021
Q2 		$487K Sell
2,072
-6,551
-76% -$1.17M 0.07% 423
2021
Q1 		$901K Hold
8,623
– – 0.21% 183
2020
Q4 		$901K Sell
8,623
-1,000
-10% -$101K 0.2% 186
2020
Q3 		$681K Buy
9,623
+4,500
+88% +$314K 0.15% 268
2020
Q2 		$329K Buy
+5,123
New +$281K 0.24% 168

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Seven Eight Capital's MRNA Position: Q3 2021 in Review

Seven Eight Capital sold out of Moderna (MRNA) in Q3 2021, closing a stake of 2,072 shares — an estimated $487K sold.

Seven Eight Capital first reported a position in MRNA in Q2 2020 and held it in 5 quarters. The position peaked at $901K in Q1 2021. 1,140 funds tracked by Wall St. Rank hold MRNA as of Q3 2021.

  • Seven Eight Capital reported no remaining Moderna position as of Q3 2021 after selling out during the quarter.
  • Seven Eight Capital sold 2,072 Moderna shares in Q3 2021, an estimated $487K.
  • Seven Eight Capital first reported a position in Moderna in Q2 2020 and held it in 5 quarters.
  • Seven Eight Capital's Moderna position peaked at $901K in Q1 2021.
  • 1,140 funds tracked by Wall St. Rank held Moderna as of Q3 2021.

Based on Seven Eight Capital's 13F filing for Q3 2021, filed 15 Nov 2021.